论文信息 - Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results. - 字舞流文

Ipilimumab (Ipi) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: 10 mg/kg cohort interim results.

J. Wolchok | F. Hodi | M. Sznol | A. Pavlick | W. Urba | O. Hamid | J. Weber | D. Minor | D. McDermott | A. Yang | W. Hwu | J. Richards | Á. Balogh | T. Michener